Cooperative effect of angiotensin AT1 and endothelin ETA receptor antagonism limits the brain damage after ischemic stroke in rat

European Journal of Pharmacology

Volumn 570, Issue 1-3, 2007, Pages 142-148

  Stenman, Emelie ^a   Jamali, Roya ^a   Henriksson, Marie ^a   Maddahi, Aida ^a   Edvinsson, Lars ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

(Rat); Angiotensin AT1 receptor; Candesartan; Cerebral ischemia; Endothelin ETA receptor; ZD1611

Indexed keywords

3 [4 [3 (3 METHOXY 5 METHYL 2 PYRAZINYLSULFAMOYL) 2 PYRIDYL]PHENYL] 2,2 DIMETHYLPROPIONIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; CANDESARTAN HEXETIL; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; TRIPHENYLTETRAZOLIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION; BRAIN SLICE; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; UPREGULATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BRAIN ISCHEMIA; DRUG SYNERGISM; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; PYRAZINES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; SULFONAMIDES; TETRAZOLES;

EID: 34547903660     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.05.049     Document Type: Article

References (42)

1. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., and Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17 (1986) 472-476
2. A receptor blockade in a transgenic, angiotensin II-dependent, rat model. Hypertension 35 (2000) 992-997
3. Britton M., de Faire U., and Helmers C. Hazards of therapy for excessive hypertension in acute stroke. Acta Med. Scand. 207 (1980) 253-257
4. Chuquet J., Benchenane K., Toutain J., MacKenzie E.T., Roussel S., and Touzani O. Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat. Stroke 33 (2002) 3019-3025
5. Dahlof B., Devereux R.B., Kjeldsen S.E., Julius S., Beevers G., de Faire U., Fyhrquist F., Ibsen H., Kristiansson K., Lederballe-Pedersen O., Lindholm L.H., Nieminen M.S., Omvik P., Oparil S., and Wedel H. Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359 (2002) 995-1003
6. Dai W.J., Funk A., Herdegen T., Unger T., and Culman J. Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 30 (1999) 2391-2399
7. Dawson D.A., Sugano H., McCarron R.M., Hallenbeck J.M., and Spatz M. Endothelin receptor antagonist preserves microvascular perfusion and reduces ischemic brain damage following permanent focal ischemia. Neurochem. Res. 24 (1999) 1499-1505
8. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22 (1999) 391-397
9. Engelhorn T., Goerike S., Doerfler A., Okorn C., Forsting M., Heusch G., and Schulz R. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 24 (2004) 467-474
10. Fukuroda T., Fujikawa T., Ozaki S., Yano M., and Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem. Biophys. Res. Commun. 199 (1994) 1461-1465
11. Groth W., Blume A., Gohlke P., Unger T., and Culman J. Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J. Hypertens. 21 (2003) 2175-2182
12. Hansen-Schwartz J., Hoel N.L., Zhou M., Xu C.B., Svendgaard N.A., and Edvinsson L. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 52 (2003) 1188-1194
13. Henriksson M., Xu C.B., and Edvinsson L. Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Brit. J. Pharmacol. 142 (2004) 1155-1161
14. B receptor alterations after cerebral ischemia. Exp. Brain Res. 178 (2007) 470-476
15. Hosomi N., Mizushige K., Kitadai M., Ohyama H., Ichihara S.I., Takahashi T., and Matsuo H. Induced hypertension treatment to improve cerebral ischemic injury after transient forebrain ischemia. Brain Res. 835 (1999) 188-196
16. Hosomi N., Nishiyama A., Ban C.R., Naya T., Takahasi T., Kohno M., and Koziol J.A. Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia. Neuroscience 134 (2005) 225-231
17. Ito T., Yamakawa H., Bregonzio C., Terron J.A., Falcon-Neri A., and Saavedra J.M. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke 33 (2002) 2297-2303
18. Lou M., Blume A., Zhao Y., Gohlke P., Deuschl G., Herdegen T., and Culman J. Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat. J. Cereb. Blood Flow Metab. 24 (2004) 536-547
19. Memezawa H., Minamisawa H., Smith M.L., and Siesjo B.K. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp. Brain Res. 89 (1992) 67-78
20. Memezawa H., Zhao Q., Smith M.L., and Siesjo B.K. Hyperthermia nullifies the ameliorating effect of dizocilpine maleate (MK-801) in focal cerebral ischemia. Brain Res. 670 (1995) 48-52
21. Menzies S.A., Hoff J.T., and Betz A.L. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 31 (1992) 100-107
22. Nakayama, et al. Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J. Biol. Chem. 269 (1994) 11628-11633
23. Nilsson T., Cantera L., Adner M., and Edvinsson L. Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries. Neurosurgery 40 (1997) 346-351
24. Nishimura Y., Ito T., Hoe K., and Saavedra J.M. Chronic peripheral administration of the angiotensin II AT (1) receptor antagonist candesartan blocks brain AT(1) receptors. Brain Res. 871 (2000) 29-38
25. Nishimura Y., Ito T., and Saavedra J.M. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31 (2000) 2478-2486
26. Parmentier S., Bohme G.A., Lerouet D., Damour D., Stutzmann J.M., Margaill I., and Plotkine M. Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury. Br. J. Pharmacol. 127 (1999) 546-552
27. Patel T.R., Galbraith S., Graham D.I., Hallak H., Doherty A.M., and McCulloch J. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischemia. J. Cereb Blood Flow Metab. 16 (1996) 950-958
28. Schrader J., Luders S., Kulschewski A., Berger J., Zidek W., Treib J., Einhaupl K., Diener H.C., and Dominiak P. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 34 (2003) 1699-1703
29. Schrader J., Luders S., Kulschewski A., Hammersen F., Plate K., Berger J., Zidek W., Dominiak P., and Diener H.C. Morbidity and mortality after stroke, Eprosartan compared with Nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 36 (2005) 1218-1226
30. Shibouta Y., Inada Y., Ojima M., Wada T., Noda M., Sanada T., Kubo K., Kohara Y., Naka T., and Nishikawa K. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole -7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole -7-carboxylate (TCV-116). J. Pharmacol. Exp. Ther. 266 (1993) 114-120
31. Stenman E., and Edvinsson L. Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke 35 (2004) 970-974
32. Stenman E., Malmsjo M., Uddman E., Gido G., Wieloch T., and Edvinsson L. Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat. Stroke 33 (2002) 2311-2316
33. Sugawara T., Kinouchi H., Oda M., Shoji H., Omae T., and Mizoi K. Candesartan reduces superoxide production after global cerebral ischemia. NeuroReport 16 (2005) 325-328
34. Szok D., Hansen-Schwartz J., and Edvinsson L. In depth pharmacological characterization of endothelin B receptors in the rat middle cerebral artery. Neurosci. Lett. 314 (2001) 69-72
35. Tuor U.I., Kondysar M.H., and Harding R.K. Effect of angiotensin II and peptide YY on cerebral and circumventricular blood flow. Peptides 9 (1988) 141-149
36. Unger T. Inhibiting renin-angiotensin in the brain: the possible therapeutic implications. Blood Press. Suppl. 1 (2001) 12-16
37. Vikman P., Beg S., Khurana T., Hansen-Schwartz J., and Edvinsson L. Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat. J. Neurosurg. 105 (2006) 438-444
38. Vincent J.M., Kwan Y.W., Chan S.L., Perrin-Sarrado C., Atkinson J., and Chillon J.M. Constrictor and dilator effects of angiotensin II on cerebral arterioles. Stroke 36 (2005) 2691-2695
39. Wachenfors A., Vikman P., Nilsson E., Edvinsson L., and Malmsjö M. Angiotensin II-induced vasodilatation in cerebral arteries is mediated by endothelium-derived hyperpolarising factor. Eur. J. Pharmacol. 531 (2006) 259-263
40. Wilson C., Hunt S.J., Tang E., Wright N., Kelly E., Palmer S., Heys C., Mellor S., James R., and Bialecki R. Pharmacological profile of ZD1611, a novel, orally active endothelin ETA receptor antagonist. J. Pharmacol. Exp. Ther. 290 (1999) 1085-1091
41. Zhou J., Ando H., Macova M., Dou J., and Saavedra J.M. Angiotensin II AT1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats. J. Cereb. Blood Flow Metab. 25 (2005) 878-886
42. Ziv I., Fleminger G., Djaldetti R., Achiron A., Melamed E., and Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke 23 (1992) 1014-1016